Dechert Advises Eventide Asset Management on Successful Final Close of US$83 Million Venture Fund

May 01, 2024

Dechert recently advised Eventide Asset Management, LLC, an investment adviser with US$7 billion in assets under management as of December 31, 2023, on the successful final close of their first private fund, Eventide Healthcare Innovation Fund I, LP, with US$83 million in committed capital.

The fund is Eventide’s first dedicated private investment vehicle and invests in private biotech companies developing innovative solutions for underserved patient populations. The core-mission of the fund is to address critical unmet needs through cutting edge therapeutics, devices and diagnostics. With an established reputation in private biotech investing, Eventide has invested over US$500 million to 38 companies as of March 31, 2024.

The Dechert team advising Eventide included financial services partners Sonia Gioseffi and Tricia Lee, and associates Inna Vysman and Jooyoon Reii Chang; and global tax partner Adrienne Baker.

About Dechert

Dechert is a global law firm that advises asset managers, financial institutions and corporations on issues critical to managing their business and their capital – from high-stakes litigation to complex transactions and regulatory matters. We answer questions that seem unsolvable, develop deal structures that are new to the market and protect clients’ rights in extreme situations. Our 1,000+ lawyers across 21 offices globally focus on the financial services, private equity, private credit, real estate, life sciences and technology sectors.

Subscribe to Dechert Updates